CURVE THERAPEUTICS
LIVE

Serial Number

79345481

Owner

Curve Therapeutics Limited

Attorney

Bruce S. Londa

Filing Date

Feb 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CURVE THERAPEUTICS Trademark

Serial Number: 79345481

CURVE THERAPEUTICS is a trademark filed by Curve Therapeutics Limited on February 25, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Curve Therapeutics Limited (4 trademarks)

158-160 North Gower Street

Entity Type: 99

Trademark Details

Filing Date

February 25, 2022

Registration Date

Not Registered

Goods & Services

Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations in the nature of biologically compatible chemical substances for scientific purposes, namely, for scientific, laboratory, clinical, and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical research

Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and neurological diseases; medical and veterinary preparations for treatment of cancer and neurological diseases; sanitary preparations for medical purposes; dietetic food and dietetic preparations adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology for the treatment of cancer and neurological diseases

Drug discovery and pharmaceutical drug development services; scientific services in the nature of scientific research, analysis, and testing in the field of pharmaceuticals and research, development and design relating thereto; medical research; technological services in the nature of pharmaceutical products development and technical consulting in the field of pharmaceutical studies and research and design relating thereto; product design and development of medical technology in the field of pharmaceuticals; product design and development of medical diagnostic apparatus; consultancy services in the field of technological development in the field of medical technology and pharmaceuticals; industrial analysis and industrial research services in the field of medical technology and pharmaceuticals; design and development of computer hardware and software in the field of clinical trials for pharmaceuticals; design and development of software in the field of clinical trials for pharmaceuticals; clinical research, namely, conducting clinical trials for others; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical and scientific research, namely, conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying, namely, scientific research; chemical analysis; chemical research; biotechnology research; consultancy in the field of biotechnology

Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease, namely, medical diagnostic testing, monitoring and reporting services; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposes

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 8, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 3, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 2, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 2, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 1, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 29, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 29, 2024 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 13, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 27, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 27, 2023 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 13, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 15, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 15, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 15, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2023 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
REFUSAL PROCESSED BY IB
Mar 6, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 14, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 14, 2023 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2023 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 18, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 17, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 21, 2022 REPR